Our expertise as a Contract Research Organization in neurological disease, natural diseases of aging and analytical method development, makes Transpharmation the perfect partner to team up with to assist in the development of product and claims for medicinal cannabis and cannabinoids for both human and companion animal patients.

To date we have received licensing for both analytical and in vivo research using cannabis products, and regularly perform studies with scheduled psychotropic drugs through Health Canada exemptions. Our expertise in neurological disease models and laboratory testing capabilities are available to help support emerging research with this category of products, and we welcome your inquires for novel approaches for model and bioanalytical development.

Examples of assays we offer include:

  • Tetrad test
  • Seizure models
  • Pain models and assays
  • Safety
  • CER
  • Bioanalytical methods developed and PK